Supplementary Figure S5. from Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial

Autor: Gordon C. Jayson, Richard J. Edmondson, Dominic G. Rothwell, Andrew J. Wallace, James P.B. O'Connor, Caroline Dive, Gerard Brady, Simon P. Pearce, Bedirhan Kilerci, D. Gareth R. Evans, Joseph Shaw, Sanjeev S. Bhaskar, Yasmina Ainaoui, Georgia King, Joanna Truelove, Emma Buckley, Chelsey Wheeler, Zena Salih, Claire L. Mitchell, Jurjees Hasan, Alexander D. Murphy, Reem D. Mahmood, W. David J. Ryder, George J. Burghel, Marcus Price, Daniel J. White, Andrew R. Clamp, Robert D. Morgan

BRCA2 reversion mutation detected in cell-free circulating DNA from patient 16.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8190683682e17f23bf7a91a183e796
https://doi.org/10.1158/1078-0432.22490383.v1

Supplementary Methodology 1 from Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial

Autor: Gordon C. Jayson, Richard J. Edmondson, Dominic G. Rothwell, Andrew J. Wallace, James P.B. O'Connor, Caroline Dive, Gerard Brady, Simon P. Pearce, Bedirhan Kilerci, D. Gareth R. Evans, Joseph Shaw, Sanjeev S. Bhaskar, Yasmina Ainaoui, Georgia King, Joanna Truelove, Emma Buckley, Chelsey Wheeler, Zena Salih, Claire L. Mitchell, Jurjees Hasan, Alexander D. Murphy, Reem D. Mahmood, W. David J. Ryder, George J. Burghel, Marcus Price, Daniel J. White, Andrew R. Clamp, Robert D. Morgan

Supplementary Methodology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac4b273d975d5742c671ed36cc435ae
https://doi.org/10.1158/1078-0432.22490380

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study

Autor: W David J Ryder, Catherine Harris, Stephen Harrow, Kate Haslett, Corinne Faivre-Finn, P. McCloskey, Matthew Hatton, Fiona McDonald, N. Bayman, Gerard G Hanna, N. Groom, Kevin Franks, Susan Harden

Publikováno v: International Journal of Radiation Oncology, Biology, Physics
Haslett, K, Bayman, N, Franks, K, Groom, N, Harden, S V, Harris, C, Hanna, G, Harrow, S, Hatton, M, McCloskey, P, McDonald, F, Ryder, W D & Faivre-Finn, C 2021, ' Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study ', International Journal of Radiation Oncology Biology Physics, vol. 109, no. 5, pp. 1341-1348 . https://doi.org/10.1016/j.ijrobp.2020.11.040

Purpose: Not all patients with stage III non-small cell lung cancer (NSCLC) are suitable for concurrent chemoradiation therapy (CRT). Local failure rate is high for sequential concurrent CRT. As such, there is a rationale for treatment intensificatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f83fe444374fe5bf2850e3159812db
https://doi.org/10.1016/j.ijrobp.2020.11.040

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

Autor: Andrew Bates, Corinne Faivre-Finn, Liz Darlison, Talal Mansy, Linda Ashcroft, Apurna Jegannathen, N. Bayman, Laura S Pemberton, Veni Ezhil, W David J Ryder, Matthew Hatton, Michael D Peake, David R Baldwin, Paul Taylor, M. Snee, W. Appel, David Gilligan, Robert C. Rintoul, John G. Edwards

Publikováno v: Journal of Clinical Oncology. 37:1200-1208

PURPOSE Prophylactic irradiation to the chest wall after diagnostic or therapeutic procedures in patients with malignant pleural mesothelioma (MPM) has been a widespread practice across Europe, although the efficacy of this treatment is uncertain. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe257f9ae7d7523050306c55b3a3f96
https://doi.org/10.1200/jco.18.01678

ACUFOCIN: Randomized clinical trial of ACUpuncture plus standard care versus standard care alone FOr Chemotherapy Induced peripheral Neuropathy (CIPN)

Autor: Andrew M Wardley, Peter A Mackereth, Vivek Misra, Peter Hall, W David J Ryder, Jacqui Stringer

Publikováno v: Journal of Clinical Oncology. 38:12003-12003

12003 Background: CIPN is a dose limiting toxicity, and a major clinical challenge. This study aims to explore the use of acupuncture with standard care (Acu +SC) against SC alone, to reduce symptoms of CIPN. Methods: A phase II, randomised, parallel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8da0bdcc83d227b27e0435be02c5295c
https://doi.org/10.1200/jco.2020.38.15_suppl.12003